<!DOCTYPE html>
<html lang="en">
    <head>
        <meta name="DC.IDENTIFIER" content="http://dx.doi.org/10.17917/WZGC-DG48" scheme="DCTERMS.UI"><title>caNanoLab DOI Landing page</title>
        <style>
            h1 { text-align: center;}
            h2 { text-align: left;}
            table { border: 1px solid #dddddd; text-align: left; padding: 8px }
            td, th { border: 1px solid #dddddd; text-align: left; padding: 8px }
            tr:nth-child(even) { background-color: #dddddd }
        </style>
    </head><body><img src="./assets/images/crdc-logo.svg" alt="CRDC General Commons Logo"><h1> caNanoLab DOI </h1><hr><p><b>Protocol Type:</b> in vitro assay</p><p><b>Protocol Name:</b> NCL Method ITA-9.2: In Vitro Assay for Assessing Nanoparticle Effects on Monocyte/Macrophage Phagocytic Function</p><p><b>Protocol Abbreviation:</b> ITA-9.2</p><p><b>Protocol Version:</b> 1.1<hr><p><b>DOI:</b> <a href = http://dx.doi.org/10.17917/WZGC-DG48>http://dx.doi.org/10.17917/WZGC-DG48</a></p><p><b>Protocol File:</b> protocols/20250627_11-51-14-319_NCL_Method_ITA-9.2.pdf<p><b>File Title:</b> NCL_Method_ITA-9.2</p><p><b>Description:</b></b> This document describes a protocol for evaluation of nanoparticle effects on the phagocytic function of immune cells. HL-60 promyelocytic cells are used as the model phagocytic cell line, and Zymosan A is used as a model bioparticle. The phagocytic activity of HL-60 cells is visualized with luminol. Luminol is a dye which is not luminescent unless exposed to the low pH of the phagolysosome. Nanoparticles may either enhance or inhibit the cell phagocytic function. Such effects are monitored by comparing the Zymosan A uptake in control cells to that of cells exposed to test nanomaterials 24 hours prior to the addition of Zymosan A.<hr><p><b>Resource Type:</b>  Protocol</p><p><b>Data Access:</b> <a href =https://general.datacommons.cancer.gov/#/data>https://general.datacommons.cancer.gov/#/data</a><p></body></html>